Tag: weight management

Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate

The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They...

Medicare Struggles to Expand Diabetes Prevention Program

Damon Diessner tried for years to slim down from his weight of more than 400 pounds, partly because his size embarrassed his wife but even...

Medicare Proposes Direct Payments to PAs, Telehealth Expansion

Medicare intends next year to allow physician assistants (PAs) to begin directly billing for their work and to expand coverage of telehealth services. It also...

Managing Early Complications After Bariatric/Metabolic Surgery

The American Gastroenterological Association recently published a clinical practice update concerning endoscopic evaluation and management of early complications after bariatric/metabolic surgery. The seven best practice...

Novel Colonic Agonist Formulation Promising for Obesity

NEW YORK (Reuters Health) – A colonic release formulation of medium-chain fatty acids (MFCA) curbed appetite and boosted levels of the anorexigenic hormone PYY in...

Digital Diabetes Coaching Systems: Too Expensive or Worthwhile?

Dr Anne L. Peters Digital coaching systems for type 2 diabetes “reduce the need for more expensive, in-person visits,” said Anne L. Peters, MD, arguing...

‘Stunning’ Twincretin Beats Semaglutide in Type 2 Diabetes

Tirzepatide, a novel “twincretin” agent, was superior to 1-mg semaglutide treatments for reducing both hemoglobin A1c levels and body weight in patients with type 2...

Time-Restricted Eating Is ‘Promising, But More Data Are Needed’

Time-restricted eating — that is, reducing the number of hours a person is allowed to eat during the day — may produce a modest 1%...

FDA Approves ‘Gamechanger’ Semaglutide for Weight Loss

The US Food and Drug Administration (FDA) has approved a 2.4 mg/week subcutaneous dose of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy, Novo Nordisk)...

Weight Gain Does Not Protect Cognition

In contrast to previous research, a new study suggests that weight gain in older adults does not preserve cognition — and may actually be detrimental....

Some NP Thyroid Lots Recalled Due to Reduced Potency

In its third voluntary recall in the past year, Acella Pharmaceuticals has announced a nationwide recall of specific lots of its popular hypothyroid treatment NP Thyroid...

Eating More Fat May Boost Borderline Low Testosterone

“Low-fat diets appear to decrease testosterone levels in men, but further randomized controlled trials are needed to confirm this effect,” the authors of a meta-analysis...

Bariatric Surgery May Cut Cancer in Obesity With Liver Disease

In a large cohort of insured working adults with severe obesity and nonalcoholic fatty liver disease (NAFLD), among those who underwent bariatric surgery, the rate of...

Another HIV Tivicay Birth Outcome: Better Infant Survival

Infants born to women with HIV who were taking dolutegravir (DTG) plus emtracitabine/tenofovir alafenamide (FTC/TAF) had significantly higher odds of surviving the first 6 months...

Weight Gain Common in Childhood Brain Tumor Survivors

Children who have been treated for brain tumors often experience significant weight gain, and new findings suggest that this could be a sign of hypothalamic-pituitary...

Psychiatrists’ Happiness, Well-Being Hit Hard by COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Events of the past year have taken a huge toll on...

Semaglutide for Weight Loss? A Good First STEP, With Caveats

The phase 3a STEP 1 trial that investigated the use of semaglutide (Novo Nordisk), a glucagon-like peptide-1 (GLP-1) agonist, for weight loss is aptly named,...

Cardiometabolic Subspecialty Is ‘One-Stop Shop’ Approach to Diabetes

A one-stop shop approach to managing the spectrum of complications in patients with type 2 diabetes with a coordinated, multidisciplinary team of clinicians has taken...

AAP Issues Guidelines for Diagnosing, Managing Eating Disorders

For too long, eating disorders have been considered a disease that afflicted mostly affluent white teenage girls, but there really is no type for eating...

Bariatric Surgery Might Reduce Severity of COVID-19 Infection

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. People with obesity who lost weight as a result of bariatric...

FDA Approves Liraglutide for Adolescents With Obesity

The Food and Drug Administration’s new indication for liraglutide (Saxenda) for weight loss in adolescents with obesity, announced on Dec. 4, received welcome as a...

Twincretin Shows Positive Effects in Phase 3 Trial in Diabetes

Tirzepatide, a novel drug that acts via two related but separate pathways of glucose control, produced positive effects in top-line results from the phase 3,...

FDA Clears First Drug for Rare Genetic Causes of Severe Obesity

The US Food and Drug Administration (FDA) has approved setmelanotide (Imcivree, Rhythm Pharmaceuticals) for weight management in adults and children as young as 6 years...

Age No Barrier to Weight Loss in Those With Morbid Obesity

Older adults should be recommended for hospital-based lifestyle interventions to reduce weight, say UK investigators after finding there was no difference in weight loss between...

In Those With Obesity, Will Losing Weight Cut COVID-19 Severity?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. As study after study piles up showing that those with obesity...